Retatrutide appears to be a new pharmaceutical in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these https://lillitbsd671625.newbigblog.com/42448050/retatrutide-a-promising-new-treatment-for-obesity